No Data
No Data
Revenues Not Telling The Story For Cartesian Therapeutics, Inc. (NASDAQ:RNAC)
Cartesian Therapeutics Announces New Employment Inducement Grants
Express News | Cartesian Therapeutics Files For Proposed Resale Or Other Disposition By Selling Stockholders Of Up To 6.3M Common Stock
Express News | Cartesian Therapeutics Files for Mixed Shelf Offering of up to $400 Mln - SEC Filing
Insider Sale: Chief Technology Officer of $RNAC (RNAC) Sells 2,901 Shares
Cartesian Therapeutics Insider Sold Shares Worth $345,134, According to a Recent SEC Filing